Keywords: Alzheimer's disease, Latrepirdine, Renewed potential, Dimebon, Mount Sinai

Rejected Alzheimer's drug latrepirdine shows new potential in early disease

Article | 31 July 2012

Print This

An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in